Coloplast CEO pleased that UK healthcare has reached settlement

Important for Coloplast that the result of the healthcare reform is out.

The United Kingdom's Department of Health has concluded a healthcare reform process that will mean a two per cent reduction in reimbursement prices for stoma and continence appliances.

Lars Rasmussen, commenting on the announcement, said, “What is important is that a settlement has been reached, and we now know what to expect. That is the main thing, both for management and our team in England, who have been following this process closely.”

 

Coloplast CEO pledges support for users after healthcare reform

Mr Rasmussen added that the company will do its best to minimize negative implications of the reform for end-users: "Price reductions are never desirable, because they can impact the range of offerings we provide our end-users. However, we will do our utmost to ensure that the changes brought on by the reform will not negatively affect our users in England."

 

Changes will affect financial results in 2009/2010

The changes are expected to reduce Coloplast's revenue and EBIT by GBP 3-4 million per year from 2010, when the reduction comes into effect. A price increase mechanism for the reimbursement of items will be reintroduced six months after the implementation of the price reduction.

Coloplast's financial expectations for the financial year 2008/2009 are not affected.